What Happened?
Newton, MA-based Chiasma Appointed Colleen Wilson as Vice President, Human Resources
About the Company
Chiasma improves the lives of patients by transforming injectable drugs into oral medications. The company`s proprietary, clinically validated Transient Permeability Enhancer (TPE®) technology enables intestinal absorption of molecules that previously had limited intestinal bioavailability. Chiasma focuses on peptide drugs, which serve a large market that is currently served only by injectables. Oral formulations offer numerous advantages, including consistent dosing and the elimination of administration site reactions. Chiasma’s lead investigational candidate, octreotide capsules, is being developed for the treatment of acromegaly.
About the Person
Human Resources executive specializing in growing life sciences companies. Particular strengths in organizational design and culture development, recruiting, compensation and benefit enhancements, corporate transitions both to commercial stage, as well as, becoming a public company. Experienced interacting with all levels within the company, as well as, the Board of Directors.
Info Source
Company Announcement
Short Profile